GlassScriptPhysician profile
Michael A Lepis
NPI 1972686079
$3,906.62
in general payments reported to CMS, 2019-2025
36 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $196 · 2021: $646 · 2022: $474 · 2023: $693 · 2024: $635 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,590.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $462.52 | 2019-2025 | Belbuca |
| Abbott Laboratories | $369.10 | 2019-2024 | Proclaim |
| Si-Bone, INC. | $312.58 | 2019-2025 | |
| Radius Health, INC. | $307.41 | 2019-2025 | |
| Medtronic, INC. | $268.60 | 2021-2024 | Cd Horizon Spinal System, Rialto Si Fusion System, Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $266.29 | 2019-2025 | Relistor |
| Nevro Corp. | $223.62 | 2019-2024 | Senza |
| Biodelivery Sciences International, INC. | $217.29 | 2019-2021 | |
| Vertos Medical, INC. | $179.05 | 2023-2024 | Mild Device Kit |
| Alphatec Spine, INC | $149.55 | 2024 | Invictus Mis |
| Scilex Pharmaceuticals INC. | $145.59 | 2019-2024 | Ztlido |
| Foundation Fusion Solutions, LLC | $140.39 | 2022-2024 | |
| Fidia Pharma USA INC. | $96.82 | 2019-2023 | Hyalgan |
| Arbor Pharmaceuticals, INC. | $93.10 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $91.49 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $58.19 | 2019 | |
| Pacira Therapeutics, INC. | $43.46 | 2019 | |
| Averitas Pharma INC. | $41.50 | 2023-2024 | Qutenza |
| Bioventus LLC | $41.44 | 2019-2021 | |
| Globus Medical, INC. | $40.87 | 2025 | Vyrsa V1, Senza |
| Medtronic USA, INC. | $37.09 | 2019-2020 | |
| Spr Therapeutics, INC | $32.23 | 2025 | Sprint Pns System |
| Valinor Pharma, LLC | $30.98 | 2023-2024 | Movantik |
| Pfizer INC. | $28.70 | 2019-2020 | |
| Assertio Therapeutics, INC. | $26.85 | 2019-2020 | |
| Horizon Therapeutics Plc | $26.54 | 2020-2022 | |
| Redhill Biopharma INC. | $26.49 | 2021 | |
| Painteq LLC | $22.38 | 2024 | Painteq |
| Djo, LLC | $20.26 | 2019 | |
| Avanos Medical | $19.36 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.03 | 2023 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $15.87 | 2022 | |
| Ethicon US, LLC | $14.39 | 2024 | Echelon Flex |
| Astrazeneca Pharmaceuticals LP | $13.77 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $13.68 | 2024 | |
| Orthogenrx INC. | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lepis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.